1. Tu Y Y. The development of new antimalarial drugs:Qinghaosu and Dihydro-Qinghaosu[J]. Chinese Medical Journal,1999,112(11):976-977. 2. Tu Y Y. The discovery of artemisinin(Qinghaosu) and gifts from Chinese medicine[J]. Nature Medicine,2011,17(10):1217-1220. 3. Klayman D L. Qinghaosu(artemisinin):an antimalarial drug from China[J]. Science,1985,228(4703):1049-1055. 4. Rosenthal P J,Meshnick S R. Hemoglobin catabolism and iron utilization by malaria parasites[J]. Molecular and Biochemical Parasitology,1996,83(2):131-139. 5. Li Y. Qinghaosu(artemisinin):chemistry and pharmacology[J]. Acta Pharmacologica Sinica,2012,33(9):1141-1146. 6. Meshnick S R. Artemisinin antimalarials:mechanisms of action and resistance[J]. Medecine Tropicale,1997,58(S1):13-17. 7. Morris C A,Duparc S,Borghini-Fuhrer I,et al. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous,intramuscular,oral or rectal administration[J]. Malaria Journal,2011,10:263. 8. Lu J J,Meng L H,Shankavaram U T,et al. Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells[J]. Biochemical Pharmacology,2010,80(1):22-30. 9. Wong J W,Yuen K H. Improved oral bioavailability of artemisinin through inclusion complexation with β and γ-cyclodextrins[J]. International Journal of Pharmaceutics,2001,227(1-2):177-185. 10. Van Nijlen T,Brennan K,Van Den Mooter G,et al. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions[J]. International journal of Pharmaceutics,2003,254(2):173-181. 11. Shahzad Y,Sohail S,Arshad M S,et al. Development of solid dispersions of artemisinin for transdermal delivery[J]. International Journal of Pharmaceutics,2013,457(1):197-205. 12. Isacchi B,Arrigucci S,La Marca G,et al. Conventional and long-circulating liposomes of artemisinin:preparation,characterization,and pharmacokinetic profile in mice[J]. Journal of Liposome Research,2011,21(3):237-244. 13. Meer T A,Moravkar K,Pawar J,et al. Crosslinked porous starch particles-a promising Carrier[J]. Polimery Medycynie,2015,45(1):11-19. 14. Glenn G M,Klamczynski A P,Woods D F,et al. Encapsulation of plant oils in porous starch microspheres[J]. Journal of Agricultural and Food Chemistry,2010,58(7):4180-4184. 15. Jiang T Y,Wu C,Gao Y K,et al. Preparation of novel porous starch microsphere foam for loading and release of poorly water soluble drug[J]. Drug development and Industrial Pharmacy,2014,40(2):252-259. 16. Ali M T,Fule R,Sav A,et al. Porous starch:a novel carrier for solubility enhancement of carbamazepine[J]. AAPS PharmSciTech,2013,14(3):919-926. 17. Gao F,Li D,Bi C H,et al. The adsorption and release characteristics of CPFX in porous starch produced through different drying methods[J]. Drying Technology,2013,31(13-14):1592-1599. 18. 唐宜轩,韩丽,张定堃,等. 多孔淀粉的制备及其在医药应用中的研究进展[J]. 中成药,2015,37(6):1321-1324. Tang Y X,Han L,Zhang D K,et al. Preparation of porous starch and its application in medicine[J]. Chinese Traditional Patent Medicine,2015,37(6):1321-1324. 19. Wu C,Wang Z Y,Zhi Z Z,et al. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs[J]. International Journal of Pharmaceutics,2011,403(1-2):162-169. 20. Zhang Z W,Huang J,Jiang S J,et al. Porous starch based self-assembled nano-delivery system improves the oral absorption of lipophilic drug[J]. International Journal of Pharmaceutics,2013,444(1-2):162-168. 21. Isacchi B,Bergonzi M C,Grazioso M,et al. Artemisinin and artemisinin plus curcumin liposomal formulations:Enhanced antimalarial efficacy against Plasmodium berghei-infected mice[J]. European Journal of Pharmaceutics and Biopharmaceutics,2012,80(3):528-534. |